Mike Sullivan
Banking and Capital Markets Executive & Board Executive Chairman
Mike Sullivan is an accomplished Banking and Capital Markets Executive with experience across the US and Australia.
Co-Founder of Horizon 3 who brings together talented teams to deliver. Mike has an established track record of success supporting growing companies. Has led the Horizon 3 team since inception and is an active investor in the life sciences sector in Australia and globally.
Previously, he worked for 20 years in financial services across wealth management, equity capital markets, corporate advisory, and banking. His two decades’ experience includes 11 years at National Australia Bank, 3 years at Ferris Baker Watts in the US which was acquired by RBC.
Mike has a Bachelor of Business Administration from Loyola College in Baltimore, Maryland USA.
Jian Sun
Entrepreneur and founder of HK Biotechnology & Board Director
Jian Sun is the Founder of Huikang Bio-Tech and Director of Huikang Group. He has a very persistent belief in the health industry and biotechnology, a forward-looking strategic vision, excellent operational capabilities, and rich management experience.
Over 20 years of operating and running Huikang Group, which continues to this day, Mr Sun has overseen 60 patents granted in China and abroad, more than 50 patents pending, and a number of awards for its research achievements with many of those commercialised in market, in China. At present, A$100,000,000 has been invested to create the Huikang Biotechnology Industrial Park equipped with international advanced scientific research and production equipment, covering R&D, manufacture and sale of new drugs, gene therapy, cosmetics and medical devices.
In 2005 Mr Sun started doing business in Australia, with Melbourne now the international headquarters for Huikang Group. Mr. Sun and Huikang Group are dedicated and committed biotechnology industry participants with a long-term view to being a key contributor of the global biotech industry to advance mankind.
Glenn Cross
Senior Corporate Advisor & Board Director
Glenn Cross has spent his career working in life sciences progressing from the lab bench to senior executive positions. His strong executive experience combined with deep laboratory experience gives him a solid understanding of the Australian and global biotech sector.
Currently he is involved in capital markets and general investment activities in North America, Asia and Australia. He is the CEO of his own investment and advisory company Red Bluff Capital. He is also a non-executive director on the board of a number of biotechnology and medical device companies.
Previously he was the Chief Operating Officer and CEO of AusBiotech for over 13 years, and has over 40 years’ experience in the life sciences sector. Glenn has held senior executive roles in both multinational and Australian companies. His expertise covers general management, sales, marketing, finance, distribution and manufacturing in the life sciences market.
Glenn also has experience in human resources, product development and manufacturing.
Claire Newstead-Sinclair
Company Secretary
Ms Newstead-Sinclair is a Chartered Accountant and Member of the Governance Institute of Australia at the Corporate Business Service Provider, Vistra Australia. Ms Newstead-Sinclair has been CFO and Company Secretary for a number of ASX listed and unlisted public and private companies in the biotechnology and healthcare sectors, including over 9 years as Senior Director of Finance, Legal & HR and Company Secretary for Cogstate Limited (ASX:CGS).
OUR
TEAM
